PYCR1 promotes the malignant progression of lung cancer through the JAK-STAT3 signaling pathway via PRODH-dependent glutamine synthesize
Background: Lung cancer is a serious threat to human life. It is of great significance to elucidate the pathogenesis of lung cancer and search for new markers. This study evaluate the clinical value of pyrroline-5-carboxylate reductase 1 (PYCR1) and explore its role and mechanisms in the malignant p...
Main Authors: | Lihong Zhang, Xinyu Zhao, Enqin Wang, Ye Yang, Liangfeng Hu, Hongkun Xu, Baojun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523323000530 |
Similar Items
-
ITPKA phosphorylates PYCR1 and promotes the progression of glioma
by: Xiangying Luo, et al.
Published: (2024-08-01) -
Survival and clinicopathological significance of PYCR1 expression in cancer: A meta-analysis
by: Yue Li, et al.
Published: (2022-09-01) -
PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets
by: Zheng Shao, et al.
Published: (2022-12-01) -
The circUbqln1, regulated by XBP1s, interplays with 14–3–3ζ to inhibit collagen synthesis and promote osteoarthritis by controlling PRODH activity and proline metabolism
by: Naibo Feng, et al.
Published: (2024-12-01) -
PYCR1 is associated with papillary renal cell carcinoma progression
by: Wang Qiu-Li, et al.
Published: (2019-08-01)